1-179992122-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014810.5(CEP350):c.296G>A(p.Arg99Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000396 in 1,550,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014810.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP350 | NM_014810.5 | c.296G>A | p.Arg99Gln | missense_variant | 5/38 | ENST00000367607.8 | NP_055625.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP350 | ENST00000367607.8 | c.296G>A | p.Arg99Gln | missense_variant | 5/38 | 1 | NM_014810.5 | ENSP00000356579.3 |
Frequencies
GnomAD3 genomes AF: 0.000231 AC: 35AN: 151504Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000153 AC: 26AN: 169578Hom.: 0 AF XY: 0.000199 AC XY: 18AN XY: 90670
GnomAD4 exome AF: 0.000414 AC: 579AN: 1399138Hom.: 0 Cov.: 31 AF XY: 0.000406 AC XY: 281AN XY: 692186
GnomAD4 genome AF: 0.000231 AC: 35AN: 151614Hom.: 0 Cov.: 31 AF XY: 0.000189 AC XY: 14AN XY: 74030
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.296G>A (p.R99Q) alteration is located in exon 5 (coding exon 4) of the CEP350 gene. This alteration results from a G to A substitution at nucleotide position 296, causing the arginine (R) at amino acid position 99 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at